AI Portfolio Summary
In 2025 Q4, Kalehua Capital Management LLC maintained a portfolio of 19 distinct positions. The most significant new addition to the portfolio was Alpha Architect 1-3 , which now represents 26.27% of the total fund value.
Total Positions
19
Quarter
2025 Q4
Top Holding
BOXX (26.3%)
Top 10 Concentration
83.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-19 of 19
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BOXX
Alpha Architect...
|
ETF | 26.27% | — |
#1
Prev: #—
|
9.5 | 230,787 | no change |
NEW
|
230,787 | $26,563,584 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XFOR
X4 Pharmaceutic...
|
Healthcare | 14.73% | — |
#2
Prev: #—
|
9.0 | 3,722,840 | no change |
NEW
|
3,722,840 | $14,891,360 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SION
Sionna Therapeu...
|
Healthcare | 8.02% | — |
#3
Prev: #—
|
7.7 | 197,072 | no change |
NEW
|
197,072 | $8,107,542 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RLAY
Relay Therapeut...
|
Healthcare | 7.54% | — |
#4
Prev: #—
|
7.0 | 901,457 | no change |
NEW
|
901,457 | $7,626,326 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CMPS
Compass Pathway...
|
Healthcare | 5.59% | — |
#5
Prev: #—
|
6.2 | 819,692 | no change |
NEW
|
819,692 | $5,655,875 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PHVS
Pharvaris NV
|
Healthcare | 5.46% | — |
#6
Prev: #—
|
5.7 | 198,772 | no change |
NEW
|
198,772 | $5,515,923 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SEPN
Septerna Inc
|
Healthcare | 5.36% | — |
#7
Prev: #—
|
5.6 | 194,544 | no change |
NEW
|
194,544 | $5,423,887 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ORKA
Oruka Therapeut...
|
Healthcare | 3.55% | — |
#8
Prev: #—
|
4.9 | 118,524 | no change |
NEW
|
118,524 | $3,592,462 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IKT
Inhibikase Ther...
|
Healthcare | 3.55% | — |
#9
Prev: #—
|
4.9 | 1,750,000 | no change |
NEW
|
1,750,000 | $3,587,500 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALLO
Allogene Therap...
|
Healthcare | 3.45% | — |
#10
Prev: #—
|
4.9 | 2,546,129 | no change |
NEW
|
2,546,129 | $3,488,197 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LONA
LeonaBio Inc
|
Healthcare | 2.95% | — |
#11
Prev: #—
|
4.7 | 393,701 | no change |
NEW
|
393,701 | $2,980,317 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MLTX
MoonLake Immuno...
|
Healthcare | 2.29% | — |
#12
Prev: #—
|
4.4 | 175,734 | no change |
NEW
|
175,734 | $2,316,174 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ORIC
Oric Pharmaceut...
|
Healthcare | 2.16% | — |
#13
Prev: #—
|
4.4 | 267,059 | no change |
NEW
|
267,059 | $2,184,543 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRCA
Verrica Pharmac...
|
Healthcare | 1.94% | — |
#14
Prev: #—
|
4.3 | 235,779 | no change |
NEW
|
235,779 | $1,959,323 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TYRA
Tyra Bioscience...
|
Healthcare | 1.94% | — |
#15
Prev: #—
|
4.3 | 74,465 | no change |
NEW
|
74,465 | $1,957,685 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRZN
Surrozen Inc
|
Healthcare | 1.87% | — |
#16
Prev: #—
|
4.2 | 385,178 | no change |
NEW
|
385,178 | $1,886,241 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TNYA
Tenaya Therapeu...
|
Healthcare | 1.41% | — |
#17
Prev: #—
|
4.1 | 2,000,000 | no change |
NEW
|
2,000,000 | $1,423,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KLRS
Kalaris Therape...
|
Healthcare | 1.17% | — |
#18
Prev: #—
|
4.0 | 139,901 | no change |
NEW
|
139,901 | $1,180,764 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DMAC
Diamedica Thera...
|
Healthcare | 0.75% | — |
#19
Prev: #—
|
3.8 | 95,359 | no change |
NEW
|
95,359 | $759,058 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-19 of 19 holdings